Common structural requirements for peroxisome proliferation by tetrazole and carboxylic acid-containing compounds.
Eacho
P I
PI
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Foxworthy
P S
PS
Lawrence
J W
JW
Herron
D K
DK
Noonan
D J
DJ
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000737:chemistry; D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D002264:Carboxylic Acids / Q000737:chemistry / Q000494:pharmacology; D002522:Chlorocebus aethiops; D000960:Hypolipidemic Agents / Q000737:chemistry*; D008830:Microbodies / Q000187:drug effects*; D008968:Molecular Conformation; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000737:chemistry / Q000494:pharmacology*; D015262:Xenobiotics / Q000737:chemistry
D000098:Acetophenones; D002264:Carboxylic Acids; D000960:Hypolipidemic Agents; D013777:Tetrazoles; D015262:Xenobiotics; D015117:5,8,11,14-Eicosatetraynoic Acid; C044660:LY 171883; C049043:LY 163443